Provided by Tiger Trade Technology Pte. Ltd.

Acumen Pharmaceuticals, Inc.

3.06
-0.0150-0.49%
Volume:208.88K
Turnover:649.16K
Market Cap:220.97M
PE:-1.87
High:3.17
Open:3.09
Low:3.04
Close:3.08
52wk High:3.60
52wk Low:1.21
Shares:72.21M
Float Shares:37.05M
Volume Ratio:0.51
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6370
EPS(LYR):-2.0035
ROE:-120.50%
ROA:-45.77%
PB:3.86
PE(LYR):-1.53

Loading ...

Aug 12, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2026

Major Issues Report

Form 8-K - Current report
Jun 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 16, 2026

Major Issues Report

Form 8-K - Current report
Jun 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2026

Major Issues Report

Form 8-K - Current report
May 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2026

Major Issues Report

Form 8-K - Current report
Apr 08, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mar 31, 2026

Correspondence

Form CORRESP - Correspondence
Mar 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2026

Major Issues Report

Form 8-K - Current report
Mar 16, 2026

Major Issues Report

Form 8-K - Current report
Mar 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 28, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities